The aim of this study was to devise a Drug Compliance Instruction Program (DCIP) for patients with type 2 diabetes taking oral hypoglycemic agents (OHA) and to assess its effectiveness. The new program was devised to improve levels of understanding and implementation in drug therapy for diabetes with the aims of contributing to and evaluating the effectiveness of such therapy. As its major features, the program uses the level of drug therapy implementation as an indicator of drug compliance and gives patients instructions on several occasions to ensure that they continue to be effective. Subjects were 109 type 2 diabetes outpatients who had HbA1c levels of 7% or more and were taking OHA. To study the effectiveness of the instructions, patients were randomly assigned to two groups : a single instruction group (n = 66), and a multiple instruction group (n = 43), whose subjects received instructions at least twice.
Introduction
Outpatients with Type 2 diabetes who had been receiving drug therapy received personal instruction. As a result, it was discovered that levels of understanding in patients taking oral hypoglycemic agents (OHA) was low in comparison to those patients on insulin. Consequently, we devised an early stage Drug Compliance Instruction Program (DCIP) for OHA patients, and this program contributed to glycemic control values improving two to four months after instruction1,2).
When implementing the early stage program, attention was focused on the low level of drug compliance. To raise levels of drug compliance, it was necessary to be able to achieve the desired effect of the drug therapy3,4). However, in this study it was found that compliance did not necessarily mean satisfactory results. The reason for this was that patients did not fully understand the significance of the drug therapy and were worried about the side effects of the medi- Thus, with the aim of making a contribution to the treatment of diabetes, we devised a new DCIP primarily focusing on raising levels of understanding and implementation of drug therapy and analyzing its efficacy. In this program, the level of implementation was taken as an indicator of compliance. A further aim was to investigate the continuity of the effectiveness of instruction, thus the subjects were divided into two groups, the single instruction group and the multiple instruction group, and the results were compared. struction group (p = 0.0 42); in addition, a significant improvement was seen four months after the initial instruction (p = 0.047 ). (Fig. 1) 
Discussion
It cannot be stressed enough that drug compliance in order to obtain the therapeutic effect of drug therapy is critical3,4). It has been reported that less than half of patients on oral hypoglycemic agents (OHA) were fully compliant with instructions for taking their medication1). Such a situation is unacceptable in the treatment of diabetes, and it is desirable that pharmacists take part in providing instruction to patients with diabetes regarding their drug therapy.
Previously when an investigation was conducted at the present institution into reasons for the decline in drug compliance, it became clear that not only did few patients understand the significance of their drug therapy but also that The level of understanding was assessed using five items, where one point was given for a correct answer with a maximum score of five points. Information is provided on patients from both groups who were subjects in the evaluation of effectiveness of multiple instruction at the time of the first instructional session. Pharmacists may play a major role in preventing secondary failure of OHA, progression to insulin, and in preventing complications by concentrating on explaining the importance of taking medication while giving instruction on general drug compliance to patients who develop no serious complications from OHA. Just how significant a role pharmacists assume in the treatment of diabetes and its efficacy became clear in this study.
In conclusion, the Drug Compliance Instruction Program significantly improved glycemic control by improving levels of understanding and compliance with drug therapy. The effectiveness was maintained when multiple instructional sessions were conducted, and the role of the pharmacist in the treatment of diabetes and its efficacy was significant. M. 
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